BioWorld MedTech

Dec. 16, 2013

BioVentrix expands European trial of Revivent-TC via LIVE procedure

An implant intended to address the cause of heart failure that was once implanted during an open-chest procedure in the operating room is now being delivered via a less invasive technique in the catheter lab in a European clinical trial. Read More

Mindray moves upmarket with Zonare acquisition

International report: Echo grants rights to MTIA for Symphony CGM in China

Washington Roundup: Budget bill offers language for medical device tax repeal

Sundance will expand psychiatric evaluation

Grants: Ixico wins grant competition in UK for dementia products

Financings roundup: Xoma to sell common stock in public offering

Med-Tech Notes

People in Places

Product Briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 22, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

Genescience presents STAT6 degrader for atopic dermatitis

BioWorld Science

Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....

Roche reports new TREM2 agonists

BioWorld Science

F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...